Mark Clark Appointed as New Chair
2 April 2024
Mark Clark Appointed as New Chair
Walk 100 Miles in May for Prostate Cancer Research 2024
27 March 2024
Walk 100 Miles in May for Prostate Cancer Research 2024
Scottish Medical Consortium approves Olaparib for use in NHSScotland
14 March 2024
Scottish Medical Consortium approves Olaparib for use in NHSScotland
NICE issues Final Draft Guidance recommending Lynparza (Olaparib) with abiraterone for patients with untreated hormone-relapsed metastatic prostate cancer
21 December 2023
NICE issues Final Draft Guidance recommending Lynparza (Olaparib) with abiraterone for patients with untreated hormone-relapsed metastatic prostate cancer
Prostate Cancer Research partners with Our Future Health
7 December 2023
Prostate Cancer Research partners with Our Future Health
Government announces major prostate cancer screening trial to end needless prostate deaths
21 November 2023
Government announces major prostate cancer screening trial to end needless prostate deaths
Darolutamide with Docetaxel approved for treatment of mHSPC in Scotland
9 October 2023
Darolutamide with Docetaxel approved for treatment of mHSPC in Scotland
PCR submits evidence to the Health and Social Care Committee as part of inquiry into men’s health
5 September 2023
PCR submits evidence to the Health and Social Care Committee as part of inquiry into men’s health
PCR partners with CAC for Prostate Cancer Awareness Month
31 August 2023
PCR partners with CAC for Prostate Cancer Awareness Month
Load more